Summary
Updated Aug 31, 2026
Constance H. Lau is Director of Matson, Inc. (MATX). 2 SEC Form 4 filings on record going back to 2025, most recently on 27 April 2026.
Recent Transactions
2Every recent SEC Form 4 transaction Constance H. Lau has reported, most recent first.
Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies Constance H. Lau files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Matthew J. Cox - $8.06M of MATX open-market activity in the last 12 months
- Peter T. Heilmann - $4.54M of MATX open-market activity in the last 12 months
- Vic S. Angoco Jr. - $1.53M of MATX open-market activity in the last 12 months
- John Warren Sullivan - $1.48M of MATX open-market activity in the last 12 months
- John P. Lauer - $1.43M of MATX open-market activity in the last 12 months
- Christopher A. Scott - $1.39M of MATX open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Constance H. Lau?
Constance H. Lau is a corporate insider, tracked as Director of Matson, Inc. (MATX). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Constance H. Lau last file a Form 4?
The most recent primary Form 4 on record is dated 27 April 2026, one of 2 filings going back to 2025.
Where can I see all of Constance H. Lau's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Constance H. Lau and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial